Context Therapeutics, Inc. (CNTX)
0.1645
-0.01
(-3.80%)
USD |
NASDAQ |
Nov 18, 16:00
0.1645
0.00 (0.00%)
After-Hours: 20:00
Context Therapeutics Net Income (Quarterly) : -7.624M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.624M |
| June 30, 2026 | -14.56M |
| March 31, 2026 | -8.681M |
| December 31, 2025 | -13.03M |
| September 30, 2025 | -9.693M |
| June 30, 2025 | -8.828M |
| March 31, 2025 | -4.577M |
| December 31, 2024 | -3.343M |
| September 30, 2024 | -17.46M |
| June 30, 2024 | -2.254M |
| March 31, 2024 | -3.668M |
| December 31, 2023 | -6.770M |
| September 30, 2023 | -5.875M |
| Date | Value |
|---|---|
| June 30, 2023 | -5.011M |
| March 31, 2023 | -6.308M |
| December 31, 2022 | -3.557M |
| September 30, 2022 | -3.854M |
| June 30, 2022 | -3.986M |
| March 31, 2022 | -3.438M |
| December 31, 2021 | -3.092M |
| September 30, 2021 | -1.443M |
| June 30, 2021 | -5.030M |
| March 31, 2021 | -0.892M |
| September 30, 2020 | -0.8762M |
| June 30, 2020 | 7.479M |
| March 31, 2020 | 0.8265M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| EyePoint, Inc. | -95.61M |
| Neumora Therapeutics, Inc. | -34.44M |
| LENZ Therapeutics, Inc. | -30.97M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Corcept Therapeutics, Inc. | 124.49M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.624M |
| EPS Diluted (Quarterly) | -0.0801 |
| Enterprise Value | -18.49M |
| Earnings Yield | -283.3% |
| Normalized Earnings Yield | -283.28 |